Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia-Reference-Cited by-同舟云学术

Efficacy and tolerability of treatment with azacitidine for 5 days in elderly patients with acute myeloid leukemia

Published:2014-08-16 Issue:6 Volume:3 Page:1570-1578
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Sadashiv Santhosh K.¹,Hilton Christie¹,Khan Cyrus¹,Rossetti James M.¹,Benjamin Heather L.¹,Fazal Salman¹,Sahovic Entezam¹,Shadduck Richard K.¹,Lister John¹

Affiliation:

1. Division of Hematology and Cellular Therapy; Allegheny Health Network; Pittsburgh Pennsylvania 15224

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference34 articles.

1. Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades;Thein;Cancer,2013

2. American Cancer Society 2014 Cancer Facts and Figures 2013 American Cancer Society Atlanta, GA http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf

3. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome;Kantarjian;Cancer,2006

5. On the value of intensive remission-induction chemotherapy in elderly patients of 65 + years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group;Löwenberg;J. Clin. Oncol.,1989

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidative stress-mediated beta cell death and dysfunction as a target for diabetes management;Frontiers in Endocrinology;2022-09-23

2. Cost-Effectiveness Analysis of Venetoclax in Combination with Azacitidine Versus Azacitidine Monotherapy in Patients with Acute Myeloid Leukemia Who are Ineligible for Intensive Chemotherapy: From a US Third Party Payer Perspective;PharmacoEconomics;2022-06-13

3. Use of Azacitidine or Decitabine for the Up-Front Setting in Acute Myeloid Leukaemia: A Systematic Review and Meta-Analysis;Cancers;2021-11-12

4. CXCR4 and CD44 dual-targeted Prussian blue nanosystem with daunorubicin loaded for acute myeloid leukemia therapy;Chemical Engineering Journal;2021-02

5. Immune responses to azacytidine in animal models of inflammatory disorders: a systematic review;Journal of Translational Medicine;2021-01-06